Gut microbiota imbalance and colorectal cancer.

The gut microbiota acts as a real organ. The symbiotic interactions between resident micro-organisms and the digestive tract highly contribute to maintain the gut homeostasis. However, alterations to the microbiome caused by environmental changes (e.g., infection, diet and/or lifestyle) can disturb this symbiotic relationship and promote disease, such as inflammatory bowel diseases and cancer. Colorectal cancer is a complex association of tumoral cells, non-neoplastic cells and a large amount of micro-organisms, and the involvement of the microbiota in colorectal carcinogenesis is becoming increasingly clear. Indeed, many changes in the bacterial composition of the gut microbiota have been reported in colorectal cancer, suggesting a major role of dysbiosis in colorectal carcinogenesis. Some bacterial species have been identified and suspected to play a role in colorectal carcinogenesis, such as Streptococcus bovis, Helicobacter pylori, Bacteroides fragilis, Enterococcus faecalis, Clostridium septicum, Fusobacterium spp. and Escherichia coli. The potential pro-carcinogenic effects of these bacteria are now better understood. In this review, we discuss the possible links between the bacterial microbiota and colorectal carcinogenesis, focusing on dysbiosis and the potential pro-carcinogenic properties of bacteria, such as genotoxicity and other virulence factors, inflammation, host defenses modulation, bacterial-derived metabolism, oxidative stress and anti-oxidative defenses modulation. We lastly describe how bacterial microbiota modifications could represent novel prognosis markers and/or targets for innovative therapeutic strategies.

• Publication year

  2016

• Venue

  World Journal of Gastroenterology

• Publication date

  2016-01-14

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3748/wjg.v22.i2.501PMID 26811603PMCID PMC4716055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The microbiome and cancer

  2018cited by this paper
• The human microbiome

  2017cited by this paper
• Colorectal Adenomas.

  2016cited by this paper
• The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.

  2015cited by this paper
• Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression

  2015cited by this paper
• Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria

  2015cited by this paper
• Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer

  2015cited by this paper
• Gut microbiome development along the colorectal adenoma–carcinoma sequence

  2015cited by this paper
• Microbes, microbiota, and colon cancer.

  2014cited by this paper
• Erratum: Gut microbial metabolism drives transformation of msh2-deficient colon epithelial cells (Cell (2014) 158 (288-299) )

  2014cited by this paper
• Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.

  2014cited by this paper
• The multifaceted role of the intestinal microbiota in colon cancer.

  2014cited by this paper
• Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype

  2014cited by this paper
• Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

  2014cited by this paper
• Association between Helicobacter pylori infection and colorectal neoplasm risk: a meta-analysis based on East Asian population.

  2014cited by this paper
• Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.

  2014cited by this paper
• The gut microbiota, bacterial metabolites and colorectal cancer

  2014cited by this paper
• Fusobacterium Is Associated with Colorectal Adenomas

  2013cited by this paper
• High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer

  2013cited by this paper
• Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer

  2013cited by this paper
• The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease.

  2013cited by this paper
• The Gut Microbiota

  2013cited by this paper
• Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

  2013cited by this paper
• NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.

  2013cited by this paper
• Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein.

  2013cited by this paper
• Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer.

  2013cited by this paper
• Bile acids in the colon, from healthy to cytotoxic molecules.

  2013cited by this paper
• The complex interplay between inflammation, the microbiota and colorectal cancer

  2013cited by this paper
• Human gut microbiome and risk for colorectal cancer.

  2013cited by this paper
• An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins

  2013cited by this paper
• Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer

  2013cited by this paper
• Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

  2013cited by this paper
• The microbiome and cancer

  2013cited by this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013cited by this paper
• Colonization of the Human Gut by E. coli and Colorectal Cancer Risk

  2013cited by this paper
• Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

  2013cited by this paper
• Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus

  2013cited by this paper
• The Gut Microbiome Modulates Colon Tumorigenesis

  2013cited by this paper
• Microbiome and immunological interactions.

  2012cited by this paper
• Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer

  2012cited by this paper
• A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases

  2012cited by this paper
• Is It Time for a Metagenomic Basis of Therapeutics?

  2012cited by this paper
• A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects

  2012cited by this paper
• Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

  2012cited by this paper
• Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice.

  2012cited by this paper
• The Commensal Microbiota

  2012cited by this paper
• Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid

  2012cited by this paper
• Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer

  2012cited by this paper
• Epigenetic imprinting by commensal probiotics inhibits the IL‐23/IL‐17 axis in an in vitro model of the intestinal mucosal immune system

  2012cited by this paper
• Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer

  2012cited by this paper
• Structure, Function and Diversity of the Healthy Human Microbiome

  2012cited by this paper
• Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans

  2012cited by this paper
• Association Between Low Colonic Short-Chain Fatty Acids and High Bile Acids in High Colon Cancer Risk Populations

  2012cited by this paper
• Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP.

  2012cited by this paper
• Gut microbial activity, implications for health and disease: the potential role of metabolite analysis.

  2012cited by this paper
• The gut microbiota in IBD

  2012cited by this paper
• TNF-α mediates macrophage-induced bystander effects through Netrin-1.

  2012cited by this paper
• The keystone-pathogen hypothesis

  2012cited by this paper
• Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

  2012cited by this paper
• Microbial Dysbiosis in Colorectal Cancer (CRC) Patients

  2011cited by this paper
• The human commensal Bacteroides fragilis binds intestinal mucin.

  2011cited by this paper
• Gut Microbiota and Inflammation

  2011cited by this paper
• Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.

  2011cited by this paper
• Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals.

  2011cited by this paper
• The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases.

  2011cited by this paper
• Restricting Microbial Exposure in Early Life Negates the Immune Benefits Associated with Gut Colonization in Environments of High Microbial Diversity

  2011cited by this paper
• Human distal gut microbiome.

  2011cited by this paper
• The Human Microbiome Project in 2011 and beyond.

  2011cited by this paper
• ClbP Is a Prototype of a Peptidase Subgroup Involved in Biosynthesis of Nonribosomal Peptides*

  2011cited by this paper
• Development of the human gastrointestinal microbiota and insights from high-throughput sequencing.

  2011cited by this paper
• Bacterial degradation of bile salts

  2011cited by this paper
• The struggle within: Microbial influences on colorectal cancer

  2011cited by this paper
• High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health.

  2011cited by this paper
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers

  2011cited by this paper
• Towards the Human Colorectal Cancer Microbiome

  2011cited by this paper
• N-Nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study.

  2011cited by this paper
• Microbial and viral pathogens in colorectal cancer.

  2011cited by this paper
• Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid

  2011cited by this paper
• Longitudinal Analysis of the Prevalence, Maintenance, and IgA Response to Species of the Order Bacteroidales in the Human Gut

  2011cited by this paper
• The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role

  2011cited by this paper
• Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis

  2011cited by this paper
• A natural prodrug activation mechanism in nonribosomal peptide synthesis.

  2011cited by this paper
• Septic arthritis and Clostridium septicum: a clue to colon cancer

  2010cited by this paper
• Study of fibroblast gene expression in response to oxidative stress induced by hydrogen peroxide or UVA with skin aging.

  2010cited by this paper
• Gut microbiota in health and disease.

  2010cited by this paper
• DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells

  2010cited by this paper
• Helicobacter pylori: a ROS-inducing bacterial species in the stomach

  2010cited by this paper
• Colorectal cancer

  2010cited by this paper
• Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells

  2010cited by this paper
• Composition, variability, and temporal stability of the intestinal microbiota of the elderly

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.

  2010cited by this paper
• Interactions of gut microbiota with functional food components and nutraceuticals.

  2010cited by this paper
• Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

  2010cited by this paper
• RETRACTED ARTICLE: Gut microbiota and related diseases: clinical features

  2010cited by this paper
• Epigenome targeting by probiotic metabolites

  2010cited by this paper
• Oxidative Stress and Oxidative Damage in Carcinogenesis

  2010cited by this paper
• Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis

  2010cited by this paper
• Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8

  2010cited by this paper
• Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues.

  2009cited by this paper

• The present and future of fecal microbiota transplantation

  2026cites this paper
• Gut Bacteria as a Biomarker for Inflammation and Cancer: Insights from Clinical and Microbial Analysis

  2026cites this paper
• Antitumor mechanism of traditional Chinese medicine: a review of gut microbiota-mediated immunotherapy.

  2026cites this paper
• E. coli K12 as a dysbiosis-driven catalyst in Colorectal Cancer: In silico identification of Cross-Species protein-protein interactions

  2026cites this paper
• The Role of the Gut Microbiome in Clinical Outcomes of Colorectal Cancer: A Systematic Review (2020-2025).

  2026cites this paper
• Assessment of Fecal Microbiota in Healthy Dogs and Dogs with Cutaneous Mast Cell Tumors Treated with Electrochemotherapy Combined with Gene Electrotransfer of IL-12

  2026cites this paper
• Gut Microbial Dysbiosis in Colorectal Cancer: Insights from Shotgun Metagenomic Profiling

  2026cites this paper
• Cross-cohort resistome and virulome gradients structure the colorectal cancer microbiome

  2026cites this paper
• Microbiota-derived metabolites in cancer: Dual roles in pathogenesis and opportunities for therapy

  2026cites this paper
• A review on the holistic exploration of health benefits and technological advancements in yoghurt incorporating fruit peels.

  2026cites this paper
• Immunomodulation Strategies in Oral Diseases: From Microbiome Manipulation to Pro-resolution Therapies.

  2026cites this paper
• ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancer

  2026cites this paper
• Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associations

  2026cites this paper
• The effect of heat stress on the hindgut microbiota and metabolites of Simmental heifers

  2026cites this paper
• Leveraging the Human Microbiome to Improve Immunotherapy Sensitivity

  2026cites this paper
• Dark side of nocturnal eating: Unraveling the emerging axis between meal timing, gut microbiota, and early-onset cancer risk.

  2026cites this paper
• Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights

  2025cites this paper
• Secondary Analysis of Public Metagenomic Data Identifies Periodontal Pathogens in the Oral but Not Gut Microbiome

  2025cites this paper
• Potential of Glycyrrhiza in the prevention of colitis-associated colon cancer.

  2025cites this paper
• Identification of microbial species and proteins associated with colorectal cancer by reanalyzing CPTAC proteomic datasets

  2025cites this paper
• Gut microbiome and colorectal cancer: From pathogenesis to treatment.

  2025cites this paper
• Biofilms: A cause for the development of cancer: A review

  2025cites this paper
• Gut–Oral Microbial Dysbiosis: A Correlated Ecosystem

  2025cites this paper
• Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer

  2025cites this paper
• Mycobiota and Antifungal Antibodies as Emerging Targets for the Diagnosis and Prognosis of Human Diseases

  2025cites this paper
• Therapeutic potential of fecal microbiota transplantation in colorectal cancer based on gut microbiota regulation: from pathogenesis to efficacy

  2025influential citation
• Effect of laxative use and laxative type on colorectal cancer risk: A pooling up analysis and evidence synthesis

  2025cites this paper
• In vitro antibacterial activity of selected plant extracts against Escherichia coli and Staphylococcus aureus bacterial strains

  2025cites this paper
• Pterostilbene Exhibited the Anticancer Effect Against 1, 2‐Dimethylhydrazine (DMH)‐Induced Colorectal Cancer via Alteration of Oxidative Stress, Inflammation and Gut Microbiota

  2025cites this paper
• Prediction of colorectal cancer based on taxonomic levels of microorganisms and discovery of taxonomic biomarkers using the Grouping-Scoring-Modeling (G-S-M) approach

  2025cites this paper
• Gut microbial β-glucuronidases and their role in the microbiome-metabolite axis in colorectal cancer

  2025cites this paper
• Characterization of the gut microbiota in patients with stage III colorectal cancer: A case-control study.

  2025cites this paper
• Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B.

  2025cites this paper
• TMOD2 and DOCK4 as Novel Gut Microbiota-Associated Biomarkers for Colorectal Adenoma: Integrated Transcriptomic Analysis and Therapeutic Target Identification

  2025cites this paper
• Expression of Bacillus in colorectal tissues is associated with improved cetuximab therapy for patients with metastatic colorectal cancer

  2025cites this paper
• Abnormal metabolic networks participate in invasion and migration of tumors of the digestive system (Review)

  2025cites this paper
• The potential role of hydrogen sulfide-autophagy axis in diseases

  2025cites this paper
• Mucosal DNA and RNA virome alterations and their interactions with human RNA and microRNA transcriptomes in colorectal polyps

  2025cites this paper
• The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancer

  2025cites this paper
• Metagenomic analysis of gut microbiota in colorectal adenocarcinoma in the MENA region

  2025cites this paper
• Ginsenosides 20R-Rg3 and Rg5 enriched black ginseng inhibits colorectal cancer tumor growth by activating the Akt/Bax/caspase-3 pathway and modulating gut microbiota in mice

  2025cites this paper
• Probiotic-Derived Metabolites from Lactiplantibacillus plantarum OC01 Reprogram Tumor-Associated Macrophages to an Inflammatory Anti-Tumoral Phenotype: Impact on Colorectal Cancer Cell Proliferation and Migration

  2025cites this paper
• Adenocarcinoma of the Interposed Colon Graft for Esophageal Substitution-Point of View from a Tertiary Center in Esophageal Surgery and Review of Literature.

  2025cites this paper
• Perioperative altered gut microbiota composition in patients with colorectal cancer: A prospective cohort study

  2025cites this paper
• Gut microbiome and cancer: Mechanisms, dysbiosis, and therapeutic prospects

  2025cites this paper
• Metformin and its Nanoformulations in Cancer Prevention and Therapy.

  2025cites this paper
• Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments

  2025cites this paper
• Helicobacter pylori infection, anti-Helicobacter pylori treatment and risk of colorectal cancer and adenoma: an observational study and a meta-analysis

  2025cites this paper
• The bridging role of neutrophils in the progression of inflammation-induced colorectal cancer.

  2025cites this paper
• The Science behind Probiotics: Exploring their Mechanisms and Therapeutic Potential.

  2025cites this paper
• Host-Microbe Interactions in Drosophila Cancer.

  2025cites this paper
• Nanomedicine Strategies in the Management of Inflammatory Bowel Disease and Colorectal Cancer

  2025cites this paper
• Personalized colorectal cancer risk assessment through explainable AI and Gut microbiome profiling

  2025influential citation
• Colorectal Cancer Mitigation Through Probiotics: Current Evidence and Future Directions

  2025cites this paper
• Characteristics of gut microbiota dysbiosis in patients with colorectal polyps

  2025cites this paper
• Fungi and cancer: unveiling the complex role of fungal infections in tumor biology and therapeutic resistance

  2025cites this paper
• Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer

  2025cites this paper
• Microbiome in Neuroblastoma: A Virgin Island in the World of Onco-Microbiome

  2025cites this paper
• Multiple primary malignancies and gut microbiome

  2025cites this paper
• Role of the oral-gut microbiota axis in pancreatic cancer: a new perspective on tumor pathophysiology, diagnosis, and treatment

  2025cites this paper
• A narrative review of the connection between gut microbiota and gastrointestinal function in patients with gastrointestinal cancer

  2025cites this paper
• GUT MICROBIOME IN CANCER: THE NEXT BIG OPPORTUNITY FOR BETTER PATIENT OUTCOMES?

  2025cites this paper
• Application of edible fungi in gut microbiota regulation

  2025cites this paper
• Gut Microbiota and Colorectal Cancer: A Balance Between Risk and Protection

  2025cites this paper
• Analysis of serum S100A12, soluble advanced glycation end products receptor, and gut microbiome in elderly patients with colorectal cancer

  2025cites this paper
• Alginate Oligosaccharide and Gut Microbiota: Exploring the Key to Health

  2025cites this paper
• The Anti-Inflammatory, Immunomodulatory, and Pro-Autophagy Activities of Probiotics for Colorectal Cancer Prevention and Treatment: A Narrative Review

  2025cites this paper
• Examining the Role of Virulence Proteins From Pathogenic Anaerobes in the Initiation of Colorectal Cancer

  2025cites this paper
• Prognostic Significance of the Comprehensive Biomarker Analysis in Colorectal Cancer

  2025cites this paper
• Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives

  2025cites this paper
• The impact of enteral immunonutrition on gut microbiota in colorectal cancer and gastric cancer patients in the preoperative period—preliminary results of randomized clinical trial

  2025cites this paper
• Effects of Okara Powder Intake on Intestinal Microbiota and Short-chain Fatty Acid Production in Japanese Adult Women: A Placebo-controlled Double-blind Study

  2025cites this paper
• Characterization of the Potential Cytotoxicity of Klebsiella pneumoniae Isolated from Colorectal Cancer Patients against a Normal Human Fibroblast Model

  2025cites this paper
• Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs.

  2025cites this paper
• Gut microbiota and chemoradiotherapy response in rectal cancer: biomarker opportunities.

  2025cites this paper
• Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer

  2025cites this paper
• Gut microbiota alterations and their association with tumorigenic pathways in colorectal cancer: insights from a pooled analysis of 109 microbiome datasets

  2025cites this paper
• Impact of Gut Microbiota on Drug Metabolism and Absorption

  2025cites this paper
• Gut colonization of Bacteroides plebeius suppresses colitis-associated colon cancer development

  2025cites this paper
• Deciphering the oncogenic influence of Pasteurella multocida: Implications of matrix metalloproteinase activation

  2025cites this paper
• A comprehensive review of probiotics and human health-current prospective and applications

  2025cites this paper
• Associations Between Malignant Tumors and Alzheimer's Disease: A Cross‐Sectional Study

  2025cites this paper
• Iron Homeostasis Dysregulation, Oro-Gastrointestinal Microbial Inflammatory Factors, and Alzheimer’s Disease: A Narrative Review

  2025cites this paper
• Natural products can be potential inhibitors of metalloproteinase II from Bacteroides fragilis to intervene colorectal cancer

  2024cites this paper
• Exploring the Role of the Gut Microbiota in Colorectal Cancer Development

  2024cites this paper
• Gut Microbiota—Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment

  2024cites this paper
• The Crucial Role of Inflammation and the Immune System in Colorectal Cancer Carcinogenesis: A Comprehensive Perspective

  2024cites this paper
• Association of ankylosing spondylitis with the risk of cancer: a meta- analysis of cohort studies.

  2024cites this paper
• Regulating Effect of Qifu Yin on Intestinal Microbiota in Mice with Memory Impairment Induced by Scopolamine Hydrobromide.

  2024cites this paper
• Role of Gut Microbiome in Cancer Treatment

  2024cites this paper
• Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis

  2024cites this paper
• Oxidative balance score: a potential tool for reducing the risk of colorectal cancer and its subsites incidences

  2024cites this paper
• The Role of the Human Microbiome in Epithelial Ovarian Cancer.

  2024cites this paper
• Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions

  2024cites this paper
• Eicosapentaenoic acid and docosahexaenoic acid suppress colonic tumorigenesis in obese mice

  2024cites this paper
• Colorectal cancer and gut microbiota

  2024cites this paper
• Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond

  2024cites this paper
• Tumour-associated and non-tumour-associated bacteria co-abundance groups in colorectal cancer

  2024cites this paper
• Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients.

  2024cites this paper
• Incidence of Colorectal Cancer After Intestinal Infection Due to Clostridioides difficile

  2024cites this paper